Abstract
Mycoplasma pneumoniae causes upper and lower respiratory-tract disease. In addition, extra-pulmonary diseases may occur at the same time as the pulmonary infection or soon after. These complications may involve neurological, dermatological, musculoskeletal, cardiovascular, gastrointestinal, renal and hematological systems, or more than one of these. Complications which are dermatological, musculoskeletal and gastrointestinal are seen most frequently (15-50%) but are not as serious as nervous, cardiac and blood disorders. The mechanism behind the development of these complications is largely immunological. The extent to which autoimmune phenomena are responsible varies, evidence for this being greatest for hematological disorders and least for gastrointestinal ones.
Keywords: Mycoplasma pneumoniae, infection, autoimmunity, immunopathology.
Current Pediatric Reviews
Title:Immunopathological Aspects of Mycoplasma pneumoniae Infection
Volume: 9 Issue: 4
Author(s): David Taylor-Robinson
Affiliation:
Keywords: Mycoplasma pneumoniae, infection, autoimmunity, immunopathology.
Abstract: Mycoplasma pneumoniae causes upper and lower respiratory-tract disease. In addition, extra-pulmonary diseases may occur at the same time as the pulmonary infection or soon after. These complications may involve neurological, dermatological, musculoskeletal, cardiovascular, gastrointestinal, renal and hematological systems, or more than one of these. Complications which are dermatological, musculoskeletal and gastrointestinal are seen most frequently (15-50%) but are not as serious as nervous, cardiac and blood disorders. The mechanism behind the development of these complications is largely immunological. The extent to which autoimmune phenomena are responsible varies, evidence for this being greatest for hematological disorders and least for gastrointestinal ones.
Export Options
About this article
Cite this article as:
Taylor-Robinson David, Immunopathological Aspects of Mycoplasma pneumoniae Infection, Current Pediatric Reviews 2013; 9 (4) . https://dx.doi.org/10.2174/157339630904131223104117
DOI https://dx.doi.org/10.2174/157339630904131223104117 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Metabolic Therapy of Heart Failure
Current Pharmaceutical Design The Long Way to Objectify Organ Damage Related to Cocaine Abuse: Oxidative Stress is the Main Culprit
Mini-Reviews in Organic Chemistry Calcium Channel Blockade and Peroxisome Proliferator Activated Receptor γ Agonism Diminish Cognitive Loss and Preserve Endothelial Function During Diabetes Mellitus
Current Neurovascular Research Atrial Fibrillation and Hypertension: “Quo Vadis”
Current Hypertension Reviews Myocardial Inflammation in Autoimmune Diseases: Investigation by Cardiovascular Magnetic Resonance and Endomyocardial Biopsy
Inflammation & Allergy - Drug Targets (Discontinued) “Endothelial Progenitor Cells” as a Therapeutic Strategy in Cardiovascular Disease
Current Vascular Pharmacology Meet Our Editorial Board Member:
Current Vascular Pharmacology Heart Failure in Sub-Saharan Africa
Current Cardiology Reviews Cellular and Molecular Mechanisms of Low Cardiac Output Syndrome after Pediatric Cardiac Surgery
Current Vascular Pharmacology Synthetic and Natural Protease Inhibitors Provide Insights into Parasite Development, Virulence and Pathogenesis
Current Medicinal Chemistry Cardiac Imaging in Heart Failure with Comorbidities
Current Cardiology Reviews Role of Antioxidants in Redox Regulation of Diabetic Cardiovascular Complications
Current Pharmaceutical Biotechnology Ryanodine Receptor - A Novel Therapeutic Target in Heart Disease
Recent Patents on Cardiovascular Drug Discovery The Involvement of PPARs in the Causes, Consequences and Mechanisms for Correction of Cardiac Lipotoxicity and Oxidative Stress
Current Molecular Pharmacology A Novel Cancer Targeting Approach Based on Estrone Anchored Stealth Liposome for Site-Specific Breast Cancer Therapy
Current Cancer Drug Targets 3D-QSAR Assisted Design of Novel 7-Deazapurine Derivatives as TNNI3K Kinase Inhibitors Using Molecular Docking and Molecular Dynamics Simulation
Letters in Drug Design & Discovery Triple Threat: The Na+/Ca2+ Exchanger in the Pathophysiology of Cardiac Arrhythmia, Ischemia and Heart Failure
Current Drug Targets Longevity Pathways (mTOR, SIRT, Insulin/IGF-1) as Key Modulatory Targets on Aging and Neurodegeneration
Current Topics in Medicinal Chemistry Purine Ionotropic (P2X) Receptors
Current Pharmaceutical Design PCSK9 Inhibition - A Novel Mechanism to Treat Lipid Disorders?
Current Pharmaceutical Design